Haemostatic parameters related to lipids and adhesion molecules

Blood Coagulation and Fibrinolysis

Volumn 10, Issue 8, 1999, Pages 465-470

  Osterud B ^a   Elvevoll, E O ^b   Brox, J ^c   Anderssen, T ^a   Eliassen, L T ^a   Halvorsen, H ^a   Hogmo P ^a   Kvernmo, H ^a   Lia, K ^a   Lund, T ^a   Olsen, J O ^a   Olsen, R L ^b   Engstad, C Sissener ^a   Vognild, E ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b NORWEGIAN INSTITUTE OF FISHERIES AND AQUACULTURE RESEARCH   (Norway)

^c NONE

Author keywords

Coagulation factors; Fibrinolysis; P selectin; Serum lipids; VCAM 1

Indexed keywords

BLOOD CLOTTING FACTOR; CELL ADHESION MOLECULE; FIBRINOGEN; LIPID; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; FEMALE; HEMOSTASIS; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING;

EID: 0033372869     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199912000-00003     Document Type: Article

References (22)

1. Stormorken H, Sakariassen KS. Hemostatic risk factors in arterial thrombosis and atherosclerosis - the thrombin-fibrin and platelet-vWF axis. Thromb Res 1997; 88:1-26.
2. Wiman B. Plasminogen activator inhibitor 1 (PAI-1) in plasma: its role in thrombotic disease. Thromb Haemost 1995; 74:71-76.
3. Andreotti F, Davies GJ, Heckett DR, Khan MI, de Bart AC, Aber VR, et al. Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke. Am J Cardiol 1988; 62:635-637.
4. Juhan-Vague I, Vague P, Alessi M, Badler C, Valadier J, Aillaud M, et al. Relationship between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1. Diabetes Metab 1987; 13:331-336.
5. Rugman FP, Jenkins JA, Duguid JK, Maggs PB, Hay CR. Prothrombin fragment F1+2: correlations with cardiovascular risk factors. Blood Coag Fibrinol 1994; 5:335-340.
6. Miller GJ, Bauer KA, Barzegar S, Cooper JA, Rosenberg RD. Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease. Thromb Haemost 1996; 75:767-771.
7. Ikeda H, Nakayama H, Oda T, Kurvano K, Muraiski A, Sugi K, et al. Soluble form of P-selectin in patients with acute myocardial infarction. Coronary Artery Dis 1994; 5:515-518.
8. Ikeda H, Takajo Y, Ichiki K, Ueno T, Maki S, Noda T, Sugi K, Imaizumi T. Increased soluble form of P-selectin in patients with unstable angina. Circulation 1995; 92:1693-1696.
9. Peter K, Nawroth P, Conradt C, Nordt T, Weiss T, Boehme M, et al. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulatory intercellular adhesion molecule-1, E-selectin, P-selectin and thrombomodulin. Arterioscler Thromb Vasc Biol 1997; 17:505-512.
10. De Caterina R, Basta G, Lazzerini G, DellÓmo G, Petrucci R, Morale M, et al. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17:2646-2654.
11. Hwong SJ, Ballantyne CM, Sharett AR, Smith LC, Davis CE, Gotto AM Jr, et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 1997; 96:4219-4225.
12. Inada Y, Okamoto H, Kanai S, Sarajas S. Faster determination of clottable fibrinogen in human plasma: an improved method and kinetic study. Clin Chem 1978; 24:351-353.
13. Østerud B, Rapaport SI. Synthesis of intrinsic factor X activator. Inhibition of the function of formed activator by antibodies to factor VIII and factor IX. Biochemistry 1970; 8:1854-1861.
14. Price JF, Fowkes FG. Risk factors and sex differential in coronary artery disease. Epidemiology 1997; 8:584-591.
15. Brunner EJ, Marmot MG, White IR, O'Brien JR, Etherington MD, Slavin BM, et al. Gender and employment grade differences in blood cholesterol, apolipoproteins and haemostatic factors in the Whitehall II study. Atherosclerosis 1993; 102:195-207.
16. Cushman M, Psaty BM, Macy E, Bovill EG, Cornell ES, Kuller LH, et al. Correlates of thrombin markers in an elderly cohort free of clinical cardiovascular disease. Arterioscler Thromb Vasc Biol 1996; 16:1163-1169.
17. Jilma B, Dirnberger E, Eichler HG, Kapiotis S. Sex differences in circulating P-selectin, E-selectin and thromboglobulin [Letter]. Br J Haematol 1996; 95:75-76.
18. Jilma B, Hildebrandt J, Kapiotis S, Wagner OF, Kitzweger E, Mullner C, et al. Effects of estradiol on circulating P-selectin. J Clin Endocrinol Metab 1996; 81:2350-2355.
19. Østerud B, Øian P. Effects of estrogen on hemostatic and leukocyte function in women. In: Rubanyi GM, Kaufmann R (editors): Estrogen and the Vessel Wall. Amsterdam: Harwood Academic Publishers; 1998. pp. 131-153.
20. Ensrud K, Grimm RH Jr. The white blood cell count and risk of coronary heart disease. Am Heart J 1992; 124:207-213.
21. Hoffman CJ, Miller RH, Hultin MB. Correlation of factor VII activity and antigens with cholesterol and triglycerides in healthy young adults. Arterioscler Thromb 1992; 12:267-270.
22. Fijnheer R, Frijns CJ, Korteweg J, Rommes H, Peters JH, Sixma JJ, Niewenhuis HK. The origin of P-selectin as a circulating plasma protein. Thromb Haemost 1997; 77:1081-1085.